Citation: Cw. Stratton, PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY PROFILE OF CLINAFLOXACIN, Clinical drug investigation, 15, 1998, pp. 19-34
Citation: J. Garau et al., FUTURE MANAGEMENT OF SERIOUS INFECTIONS WITH QUINOLONES - PLACE OF CLINAFLOXACIN - QUESTIONS AND ANSWERS, Clinical drug investigation, 15, 1998, pp. 47-48
Citation: Pe. Coudron et Cw. Stratton, THE BACTERICIDAL ACTIVITY OF CLARITHROMYCIN VERSUS AMPICILLIN ALONE AND IN COMBINATION WITH OMEPRAZOLE AND OR BISMUTH AGAINST CLARITHROMYCIN-SUSCEPTIBLE AND. CLARITHROMYCIN-RESISTANT STRAINS OF HELICOBACTER-PYLORI/, Diagnostic microbiology and infectious disease, 32(1), 1998, pp. 39-44
Authors:
KERNODLE DS
CLASSEN DC
STRATTON CW
KAISER AB
Citation: Ds. Kernodle et al., ASSOCIATION OF BORDERLINE OXACILLIN-SUSCEPTIBLE STRAINS OF STAPHYLOCOCCUS-AUREUS WITH SURGICAL-WOUND INFECTIONS, Journal of clinical microbiology, 36(1), 1998, pp. 219-222
Authors:
FILE TM
BARTLETT JG
CASSELL GH
GAYDOS CA
GRAYSTON JT
HAMMERSCHLAG MR
JONES RB
KAHN JB
MARRIE TJ
RAMIREZ JA
SAIKKU P
SCHACHTER J
SCHUMACHER HR
STAMM WE
STRATTON CW
YU VL
Citation: Tm. File et al., THE IMPORTANCE OF CHLAMYDIA-PNEUMONIAE AS A PATHOGEN - THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA-PNEUMONIAE INFECTIONS, Infectious diseases in clinical practice, 6, 1997, pp. 28-31
Citation: Sj. Antony et al., HIGH-LEVEL AMINOGLYCOSIDE-RESISTANT ENTEROCOCCUS CAUSING ENDOCARDITISSUCCESSFULLY TREATED WITH A COMBINATION OF AMPICILLIN, IMIPENEM AND VANCOMYCIN, Scandinavian journal of infectious diseases, 29(6), 1997, pp. 628-630
Authors:
BRANDT CM
ROUSE M
LAUE N
STRATTON CW
WILSON WR
STECKELBERG JM
Citation: Cm. Brandt et al., IMPORTANCE OF USING RELAPSE STUDIES OR TESTS FOR DETECTION OF ANTIBIOTIC-RESISTANCE BEFORE CONSIDERING THAT A TREATMENT FOR MULTIDRUG-RESISTANT ENTEROCOCCAL EXPERIMENTAL ENDOCARDITIS IS EFFECTIVE - REPLY, The Journal of infectious diseases, 175(1), 1997, pp. 233-233
Citation: Cw. Stratton et Pe. Coudron, BISMUTH-MEDIATED DISRUPTION OF THE GLYCOCALYX CELL-WALL OF HELICOBACTER-PYLORI - EVIDENCE FOR A MECHANISM OF ACTION FOR BISMUTH SALTS, Gastroenterology, 112(4), 1997, pp. 1098-1098
Citation: Cw. Stratton et Pe. Coudron, IN-VITRO EVALUATION OF THE IMPORTANCE OF BISMUTH IN COMBINATION THERAPY OF HELICOBACTER-PYLORI INFECTIONS CAUSED BY METRONIDAZOLE-RESISTANTOR CLARITHROMYCIN-RESISTANT STRAINS, Gastroenterology, 112(4), 1997, pp. 1098-1098
Citation: Sj. Antony et al., LACTOBACILLUS BACTEREMIA - DESCRIPTION OF THE CLINICAL COURSE IN ADULT PATIENTS WITHOUT ENDOCARDITIS, Clinical infectious diseases, 23(4), 1996, pp. 773-778
Authors:
BRANDT CM
ROUSE MS
LAUE NW
STRATTON CW
WILSON WR
STECKELBERG JM
Citation: Cm. Brandt et al., EFFECTIVE TREATMENT OF MULTIDRUG-RESISTANT ENTEROCOCCAL EXPERIMENTAL ENDOCARDITIS WITH COMBINATIONS OF CELL WALL-ACTIVE AGENTS, The Journal of infectious diseases, 173(4), 1996, pp. 909-913
Authors:
HAAS DW
STRATTON CW
GRIFFIN JP
WEEKS L
ALLS SC
Citation: Dw. Haas et al., DIMINISHED ACTIVITY OF CEFTIZOXIME IN COMPARISON TO CEFOTAXIME AND CEFTRIAXONE AGAINST STREPTOCOCCUS-PNEUMONIAE, Clinical infectious diseases, 20(3), 1995, pp. 671-676
Citation: Cw. Stratton et al., IN-VITRO KILLING OF PENICILLIN-SUSCEPTIBLE, PENICILLIN-INTERMEDIATE, AND PENICILLIN-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE BY CEFOTAXIME, CEFTRIAXONE, AND CEFTIZOXIME - A COMPARISON OF BACTERICIDAL AND INHIBITORY ACTIVITY WITH ACHIEVABLE CSF LEVELS, Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 35-42
Citation: Pe. Coudron et Cw. Stratton, FACTORS AFFECTING GROWTH AND SUSCEPTIBILITY TESTING OF HELICOBACTER-PYLORI IN LIQUID-MEDIA, Journal of clinical microbiology, 33(4), 1995, pp. 1028-1030
Citation: Jm. Hyatt et al., IN-VITRO PHARMACODYNAMICS OF PIPERACILLIN, PIPERACILLIN-TAZOBACTAM, AND CIPROFLOXACIN ALONE AND IN COMBINATION AGAINST STAPHYLOCOCCUS-AUREUS, KLEBSIELLA-PNEUMONIAE, ENTEROBACTER-CLOACAE, AND PSEUDOMONAS-AERUGINOSA, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1711-1716
Citation: Pe. Coudron et Cw. Stratton, USE OF TIME-KILL METHODOLOGY TO ASSESS ANTIMICROBIAL COMBINATIONS AGAINST METRONIDAZOLE-SUSCEPTIBLE AND METRONIDAZOLE-RESISTANT STRAINS OF HELICOBACTER-PYLORI, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2641-2644
Citation: Pe. Coudron et Cw. Stratton, UTILIZATION OF TIME-KILL KINETIC METHODOLOGIES FOR ASSESSING THE BACTERICIDAL ACTIVITIES OF AMPICILLIN AND BISMUTH, ALONE AND IN COMBINATION, AGAINST HELICOBACTER-PYLORI IN STATIONARY AND LOGARITHMIC GROWTH PHASES, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 66-69
Authors:
BAUERNFEIND A
THORNSBERRY C
GRASSI GG
PAINTER BG
PETERS G
SHLAES DM
STRATTON CW
Citation: A. Bauernfeind et al., QUINOLONE RESISTANCE IN GRAM-POSITIVE BACTERIA - PANEL DISCUSSION, Infectious diseases in clinical practice, 3, 1994, pp. 190000133-190000135
Citation: Ce. Cherubin et Cw. Stratton, ASSESSMENT OF THE BACTERICIDAL ACTIVITY OF SPARFLOXACIN, OFLOXACIN, LEVOFLOXACIN, AND OTHER FLUOROQUINOLONES COMPARED WITH SELECTED AGENTS OF PROVEN EFFICACY AGAINST LISTERIA-MONOCYTOGENES, Diagnostic microbiology and infectious disease, 20(1), 1994, pp. 21-25
Citation: Sr. Norris et al., PRODUCTION OF A-VARIANT AND C-VARIANT OF STAPHYLOCOCCAL BETA-LACTAMASE BY METHICILLIN-RESISTANT STRAINS OF STAPHYLOCOCCUS-AUREUS, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1649-1650
Authors:
SIMON NE
BUSTER BL
TOWNSEND GC
STRATTON CW
SCHELD WM
Citation: Ne. Simon et al., COMBINATION ANTIBIOTIC-THERAPY FOR ANTIBIOTIC-RESISTANT STREPTOCOCCUS-PNEUMONIAE (SP) MENINGITIS, Clinical research, 42(2), 1994, pp. 10000298-10000298